Knockdown of GNL3L Alleviates the Progression of COPD Through Inhibiting the ATM/p53 Pathway

References

• Soriano JB, Kendrick PJ, Paulson KR; Collaborators GCRD. Prevalence and attributable health burden of chronic respiratory diseases, 1990–2017 a systematic analysis for the Global Burden of Disease Study 2017. Lancet Respir Med. 2020;8(6):585–596. doi:10.1016/S2213-2600(20)30105-3
   PubMed Web of Science ®Google Scholar
• Wu J, Zhao X, Xiao C, et al. The role of lung macrophages in chronic obstructive pulmonary disease. Respir Med. 2022;205:107035. doi:10.1016/j.rmed.2022.107035
   PubMedGoogle Scholar
• Thoompumkal IJ, Subba Rao MR, Kumaraswamy A, Krishnan R, Mahalingam S. GNL3L Is a Nucleo-Cytoplasmic Shuttling Protein: role in Cell Cycle Regulation. PLoS One. 2015;10(8):e0135845. doi:10.1371/journal.pone.0135845
   PubMedGoogle Scholar
• Kannathasan T, Kuo WW, Chen MC, et al Chemoresistance-associated silencing of miR-4454 promotes colorectal cancer aggression through the GNL3L and NF-κB pathway. Cancers (Basel). 2020;12(5):1231. doi:10.3390/cancers12051231
   PubMedGoogle Scholar
• Dai G, Guo Z, Chen H, et al. High expression of guanine nucleotide-binding protein-like-3-like is associated with poor prognosis in esophageal cancer. Medicine. 2021;100(21):e25993. doi:10.1097/MD.0000000000025993
   PubMedGoogle Scholar
• Thoompumkal IJ, Rehna K, Anbarasu K, Mahalingam S. Leucine Zipper down-regulated in Cancer-1 (LDOC1) interacts with Guanine nucleotide binding protein-like 3-like (GNL3L) to modulate Nuclear Factor-kappa B (NF-κB) signaling during cell proliferation. Cell Cycle. 2016;15(23):3251–3267.
   PubMed Web of Science ®Google Scholar
• Halaby MJ, Hibma JC, He J, Yang DQ. ATM protein kinase mediates full activation of Akt and regulates glucose transporter 4 translocation by insulin in muscle cells. Cell Signal. 2008;20(8):1555–1563. doi:10.1016/j.cellsig.2008.04.011
   PubMed Web of Science ®Google Scholar
• Wang H, Guo M, Wei H, Chen Y. Targeting p53 pathways: mechanisms, structures, and advances in therapy. Signal Transduct Target Ther. 2023;8(1):92. doi:10.1038/s41392-023-01347-1
   PubMed Web of Science ®Google Scholar
• Yamamura K, Nojiri M, Nishiki K, et al. Serum derivatives of reactive oxygen metabolites are associated with severity of chronic obstructive pulmonary disease and affected by a p53 gene polymorphism. Int J Chron Obstruct Pulmon Dis. 2022;17:1589–1600. doi:10.2147/COPD.S366792
   PubMed Web of Science ®Google Scholar
• Uddin MA, Barabutis N. P53 in the impaired lungs. DNA Repair (Amst). 2020;95:102952. doi:10.1016/j.dnarep.2020.102952
   PubMed Web of Science ®Google Scholar
• Liu G, Park Y-J, Tsuruta Y, Lorne E, Abraham E. p53 Attenuates Lipopolysaccharide-Induced NF-κB activation and acute lung Injury 1. J Immunol. 2009;182(8):5063–5071. doi:10.4049/jimmunol.0803526
   PubMedGoogle Scholar
• Jiang C, Liu G, Luckhardt T, et al. Serpine 1 induces alveolar type II cell senescence through activating p53-p21-Rb pathway in fibrotic lung disease. Aging Cell. 2017;16(5):1114–1124. doi:10.1111/acel.12643
   PubMed Web of Science ®Google Scholar
• Disease GIfCOL. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Report [EB/OL]; 2022.
   Google Scholar
• Cho WK, Lee CG, K LK. COPD as a disease of immunosenescence. Yonsei Med J. 2019;60(5):407–413. doi:10.3349/ymj.2019.60.5.407
   PubMed Web of Science ®Google Scholar
• Zhu D, Ma N, Chen L, Huang J, Zhong X. Verification of the role of spiperone in the treatment of COPD through bioinformatics analysis. Int Immunopharmacol. 2021;101:108308. doi:10.1016/j.intimp.2021.108308
   PubMed Web of Science ®Google Scholar
• Chen L, Zhu D, Huang J, Zhang H, Zhou G, Zhong X. Identification of hub genes associated with COPD through integrated bioinformatics analysis. Int J Chron Obstruct Pulmon Dis. 2022;17:439–456. doi:10.2147/COPD.S353765
   PubMed Web of Science ®Google Scholar
• Yang YC, Zhang MY, Liu JY, Jiang YY, Ji XL, Qu YQ. Identification of ferroptosis-related hub genes and their association with immune infiltration in chronic obstructive pulmonary disease by bioinformatics analysis. Int J Chron Obstruct Pulmon Dis. 2022;17:1219–1236. doi:10.2147/COPD.S348569
   PubMed Web of Science ®Google Scholar
• Bo Z, Huang S, Li L, et al. EGR2 is a hub-gene in myocardial infarction and aggravates inflammation and apoptosis in hypoxia-induced cardiomyocytes. BMC Cardiovasc Disord. 2022;22(1):373. doi:10.1186/s12872-022-02814-3
   PubMedGoogle Scholar
• Simei T, Zhang H, Yang X, et al. Screening of cervical cancer-related hub genes based on comprehensive bioinformatics analysis. Cancer Biomark. 2021;32(3):303–315. doi:10.3233/CBM-203262
   PubMedGoogle Scholar
• Tang D, Zhao X, Zhang L, Wang Z, Wang C. Identification of hub genes to regulate breast cancer metastasis to brain by bioinformatics analyses. J Cell Biochem. 2019;120(6):9522–9531. doi:10.1002/jcb.28228
   PubMed Web of Science ®Google Scholar
• Rao MR, Kumari G, Balasundaram D, Sankaranarayanan R, Mahalingam S. A novel lysine-rich domain and GTP binding motifs regulate the nucleolar retention of human guanine nucleotide binding protein, GNL3L. J Mol Biol. 2006;364(4):637–654.
   PubMed Web of Science ®Google Scholar
• Li CC, Lu CY, Hsu CH, et al. Calycosin inhibits gemcitabine-resistant lung cancer cells proliferation through modulation of the LDOC1/GNL3L/NFκB. Chin J Physiol. 2023;66(4):189–199. doi:10.4103/cjop.CJOP-D-23-00009
   PubMedGoogle Scholar
• Birch J, Barnes PJ, Passos JF. Mitochondria, telomeres and cell senescence: implications for lung ageing and disease. Pharmacol Ther. 2018;183:34–49.
   PubMed Web of Science ®Google Scholar
• Sagiv A, Bar-Shai A, Levi N, et al. p53 in bronchial club cells facilitates chronic lung inflammation by promoting senescence. Cell Rep. 2018;22(13):3468–3479. doi:10.1016/j.celrep.2018.03.009
   PubMedGoogle Scholar
• Uddin MA, Akhter MS, Kubra K-T, Barabutis N. P53 deficiency potentiates LPS-Induced acute lung injury in vivo. Curr Res Physiol. 2020;3:30–33. doi:10.1016/j.crphys.2020.07.001
   PubMedGoogle Scholar
• Guevara NV, Kim H-S, Antonova EI, Chan L. The absence of p53 accelerates atherosclerosis by increasing cell proliferation in vivo. Nat Med. 1999;5(3):335–339. doi:10.1038/6585
   PubMed Web of Science ®Google Scholar
• Kurotani R, Shima R, Miyano Y, et al. SCGB3A2 Inhibits acrolein-induced apoptosis through decreased p53 phosphorylation. Acta Histochem Cytochem. 2015;48(2):61–68. doi:10.1267/ahc.14065
   PubMed Web of Science ®Google Scholar
• Volonte D, Kahkonen B, Shapiro S, Di Y, Galbiati F. Caveolin-1 expression is required for the development of pulmonary emphysema through activation of the ATM-p53-p21 pathway*. J Biol Chem. 2009;284(9):5462–5466. doi:10.1074/jbc.C800225200
   PubMed Web of Science ®Google Scholar
• Zeng M, Zhang X, Xing W, Wang Q, Liang G, He Z. Cigarette smoke extract mediates cell premature senescence in chronic obstructive pulmonary disease patients by up-regulating USP7 to activate p300-p53/p21 pathway. Toxicol Lett. 2022;359:31–45. doi:10.1016/j.toxlet.2022.01.017
   PubMed Web of Science ®Google Scholar
• Tiwari N, Marudamuthu AS, Tsukasaki Y, Ikebe M, Fu J, Shetty S. p53- and PAI-1-mediated induction of C-X-C chemokines and CXCR2: importance in pulmonary inflammation due to cigarette smoke exposure. Am J Physiol Lung Cell Mol Physiol. 2016;310(6):L496–L506. doi:10.1152/ajplung.00290.2015
   PubMedGoogle Scholar